|
16.11.2018 |
EN |
Official Journal of the European Union |
C 417/29 |
Prior notification of a concentration
(Case M.9153 — CDC/Meridiam/FICA-HPCI)
Candidate case for simplified procedure
(Text with EEA relevance)
(2018/C 417/11)
1.
On 8 November 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).This notification concerns the following undertakings:
|
— |
Caisse des dépôts et consignations (‘CDC’, France), |
|
— |
Meridiam Transition (‘Meridiam’, France), controlled by Meridiam SAS, |
|
— |
FICA-HPCI (France), controlled by Meridiam. |
CDC and Meridiam acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of FICA-HPCI.
The concentration is accomplished by way of purchase of shares.
2.
The business activities of the undertakings concerned are:|
— |
CDC is a French public institution with a special legal status, active in the management of private funds to which public authorities wish to provide special protection and in the financing of public-interest investment projects (transport, environment, transmission of electricity, etc.), |
|
— |
Meridiam is a French incorporated company, mainly active in management of infrastructure investments, especially in the sectors of transport, public services and energy generation, |
|
— |
FICA-HPCI is a holding company currently holding two project companies, FICAP and COGECAP. FICAP will be active in the production of wood pellets and COGECAP will be active in electricity generation and heating. |
3.
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.
4.
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.9153 — CDC/Meridiam/FICA-HPCI
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
|
Email: COMP-MERGER-REGISTRY@ec.europa.eu |
|
Fax +32 22964301 |
|
Postal address: |
|
European Commission |
|
Directorate-General for Competition |
|
Merger Registry |
|
1049 Bruxelles/Brussel |
|
BELGIQUE/BELGIË |
(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).